IDEX Biometrics ASA: Mandatory notification of trades - 19 June 2025
IDEX Biometrics ASA (IDEX) · publisert 20. juni 2025 kl. 04:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| PDMR Kristian Flaten via Caprock AS | CFO | Tegning Emisjon/tegning | 25 000 000 | 0,01 NOK | 19. juni 2025 | NO0013107490 | XOFF - Outside a trading venue |
| PDMR Morten Opstad via K-Konsult AS | Styreleder | Tegning Emisjon/tegning | 30 000 000 | 0,01 NOK | 19. juni 2025 | NO0013107490 | XOFF - Outside a trading venue |
| Anders Storbråten | CEO | Tegning Emisjon/tegning | 110 000 000 | 0,01 NOK | 19. juni 2025 | NO0013107490 | XOFF - Outside a trading venue |
| Annika Olsson | Styremedlem | Tegning Emisjon/tegning | 10 000 000 | 0,01 NOK | 19. juni 2025 | NO0013107490 | XOFF - Outside a trading venue |
| Morten Opstad | Styreleder | Tegning Emisjon/tegning | 20 000 000 | 0,01 NOK | 19. juni 2025 | NO0013107490 | XOFF - Outside a trading venue |
Vedlegg
- 2025-06-19 K Konsult notice.pdf (application/pdf, originaldokument)
- 2025-06-19 Anders Storbraten notice.pdf (application/pdf, originaldokument)
- 2025-06-19 Annika Olsson notice.pdf (application/pdf, originaldokument)
- 2025-06-19 Morten Opstad notice.pdf (application/pdf, originaldokument)
- 2025-06-19 Caprock notice.pdf (application/pdf, originaldokument)
Meldingstekst
Reference is made to the stock exchange notice from IDEX Biometrics ASA on 15
June 2025 regarding the share issue to personnel. The subscription and
allocation have been completed on 19 June 2025.
IDEX Biometrics ASA informs of primary insider transactions as listed in the
attached notifications.
For further information contact:
Kristian Flaten, CFO, Tel: +47 95092322
E-mail: ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)
About this notice:
This notice was issued by Kristian Flaten, CFO, on 20 June 2025 at 04:00 CET on
behalf of IDEX Biometrics ASA. This information is subject to the disclosure
requirements pursuant to Article 19 of the EU Market Abuse Regulation and
Section 5-12 of the Norwegian Securities Trading Act.